Amrize (NYSE:AMRZ) Downgraded by Wall Street Zen to Sell

Amrize (NYSE:AMRZ) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports.

A number of other analysts also recently commented on AMRZ. Wells Fargo & Company dropped their price objective on Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a report on Friday, October 30th. Stephens cut their target price on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 12th. Longbow Research assumed coverage on Amrize in a report on Monday, October 12th. They set a “buy” rating for the company. Weiss Ratings downgraded shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, October 8th. Finally, Truist Financial cut their price target on shares of Amrize from $48.00 to $35.00 and set a “hold” rating for the company in a report on Monday, October 5th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Amrize presently has a consensus rating of “Hold” and a consensus price target of $49.06.

Amrize Stock Down 1.8%

Shares of NYSE AMRZ opened at $41.90 on Friday. The firm has a 50-day moving average price of $39.53 and a 200 day moving average price of $50.30. Amrize has a 52 week low of $35.78 and a 52 week high of $65.94. The company has a quick ratio of 0.67, a current ratio of 1.07 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $23.17 billion, a price-to-earnings ratio of 18.96, a price-to-earnings-growth ratio of 1.68 and a beta of 0.04.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The company had revenue of $3.77 billion during the quarter. During the same period last year, the firm earned $0.98 EPS. Amrize’s quarterly revenue was up 2.6% on a year-over-year basis. Equities research analysts anticipate that Amrize will post 2.30 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Mario Gross purchased 3,568 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The stock was acquired at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the purchase, the insider owned 38,485 shares of the company’s stock, valued at approximately $1,793,401. This trade represents a 10.22% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jacques Sanche purchased 4,150 shares of Amrize stock in a transaction on Wednesday, August 26th. The stock was purchased at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the completion of the transaction, the director owned 9,766 shares of the company’s stock, valued at approximately $439,665.32. This represents a 73.90% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders bought 48,983 shares of company stock valued at $2,158,755. Insiders own 0.54% of the company’s stock.

Hedge Funds Weigh In On Amrize

Institutional investors have recently bought and sold shares of the stock. Caldwell Sutter Capital Inc. raised its position in Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock valued at $150,000 after purchasing an additional 275 shares during the last quarter. Grove Bank & Trust raised its position in Amrize by 2.1% during the 3rd quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock worth $653,000 after buying an additional 353 shares during the last quarter. Norman Fields Gottscho Capital Management LLC lifted its position in shares of Amrize by 4.3% during the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock worth $614,000 after purchasing an additional 475 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in Amrize by 3.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 14,506 shares of the company’s stock worth $542,000 after acquiring an additional 543 shares during the period. Finally, Choreo LLC boosted its position in shares of Amrize by 4.2% during the third quarter. Choreo LLC now owns 17,713 shares of the company’s stock worth $662,000 after purchasing an additional 706 shares in the last quarter.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.